Charlotte Janssens

Charlotte Janssens

Auto-generated profile, based on publicly available information

Charlotte Janssens

Vrije Universiteit Brussel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2022 in Human Reproduction Update
Verified
Journal Article
Closed access
PDF file
AKAnnelore Van Der Kelen
Annelore Van Der Kelen
ÖOÖzlem Okutman
Özlem Okutman
EJElodie Javey
Elodie Javey
MSMünevver Serdarogullari
Münevver Serdarogullari
CJCharlotte Janssens
Charlotte Janssens
SVStéphane Viville
Stéphane Viville
As in other domains of medicine, high-throughput sequencing methods have led to the identification of an ever-increasing number of gene variants in the fields of both male and female infertility. The increasing number of recently identified genes allows an accurate diagnosis for previously idiopathic cases of female infertility and more appropriate patient care. However, robust evidence of the gene–disease relationships (GDR) allowing the proper translation to clinical application is still missing in many cases. An evidence-based curation of currently identified genes involved in female infertility and differences in sex development (DSD) would significantly improve both diagnostic performance and genetic research. We therefore performed a systematic review to summarize current knowledge and assess the available GDR. PRISMA guidelines were applied to curate all available information from PubMed and Web of Science on genetics of human female infertility and DSD leading to infertility, from 1 January 1988 to 1 November 2021. The reviewed pathologies include non-syndromic as well as syndromic female infertility, and endocrine and reproductive system disorders. The evidence that an identified phenotype is caused by pathogenic variants in a specific gene was assessed according to a standardized scoring system. A final score (no evidence, limited, moderate, strong, or definitive) was assigned to every GDR. A total of 45 271 publications were identified and screened for inclusion of which 1078 were selected for gene and variant extraction. We have identified 395 genes and validated 466 GDRs covering all reported monogenic causes of female infertility and DSD. Furthermore, we present a genetic diagnostic flowchart including 105 genes with at least moderate evidence for female infertility and suggest recommendations for future research. The study did not take into account associated genetic risk factor(s) or oligogenic/polygenic causes of female infertility. We have comprehensively reviewed the existing research on the genetics of female infertility and DSD, which will enable the development of diagnostic panels using validated genes. Whole genome analysis is shifting from predominantly research to clinical application, increasing its diagnostic potential. These new diagnostic possibilities will not only decrease the number of idiopathic cases but will also render genetic counselling more effective for infertile patients and their families. Current evidence supports using 105 genes in panels to screen for female infertility and differences in sex development.

25 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
EDEdouard Couvreu de Deckersberg
Edouard Couvreu de Deckersberg
YLYingnan Lei
Yingnan Lei
NKNuša Krivec
Nuša Krivec
AHAnfien Huyghebaert
Anfien Huyghebaert
MDMai Chi Duong
Mai Chi Duong
CSClaudia Spits
Claudia Spits
Human pluripotent stem cells (hPSC) are increasingly used in clinical trials, with retinal pigment epithelium (RPE) being among the most transplanted cell types. However, hPSC frequently acquire chromosomal abnormalities, whose impact on differentiation and transplant safety is incompletely understood. In this work, we investigate how aneuploidy influences the progression of hPSC through undirected RPE differentiation. Large-scale omics analysis of genetically normal hPSC cultures reveals pervasive low-grade mosaicism, with 3–6% of cells carrying different aneuploidies. During undirected differentiation, all aneuploid cells are lost except those with a gain of chromosome arm 1q. These cells differentiate efficiently only when co-cultured with wild-type cells, which promote neural differentiation through paracrine signals that 1q-gain cells are uniquely receptive to. This interaction enables 1q-gain cells not only to persist but to eventually dominate the culture, owing to their competitive advantage.

29 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YLYingnan Lei
Yingnan Lei
NKNusa Krivec
Nusa Krivec
ASArkajyoti Sarkar
Arkajyoti Sarkar
MDMai Chi Duong
Mai Chi Duong
AHAnfien Huyghebaert
Anfien Huyghebaert
CSClaudia Spits
Claudia Spits
Background: Gains of chromosome 20q11.21 are among the most common culture-acquired abnormalities in human pluripotent stem cells (hPSC), conferring a well-defined survival advantage while altering differentiation capacity. However, it remains unclear whether this advantage persists during differentiation, how the aneuploidy alters ectodermal and retinal pigment epithelium (RPE) lineage specification, and which genes within the minimal amplicon drive these effects. Methods: We used three isogenic human embryonic stem cell line pairs (wild-type and 20q11.21 gain) and assessed their behaviour in two neuroectoderm differentiation systems: directed neuroectoderm induction (dual SMAD inhibition) and long-term spontaneous RPE differentiation. Competitive dynamics were measured in mixed cultures, and lineage outcomes were analysed using immunostaining, gene expression profiling and single-cell RNA sequencing. To identify driver genes, we generated BCL2L1 and ID1 overexpression lines and tested their effects under both directed and spontaneous differentiation conditions. Results: Across all lines and conditions, 20q cells expanded from a minor fraction to dominate mixed cultures, indicating that their competitive advantage persists beyond the undifferentiated state. Despite this dominance, pure 20q cells failed to specify to neuroectoderm or RPE. Single-cell transcriptomics revealed consistent diversion toward non-neural ectodermal and extraembryonic fates. Mechanistically, overexpression of BCL2L1 and ID1 alone or in combination impaired neuroectoderm specification, while synergistic effect of both genes promoted non-neural ectodermal outcomes under directed differentiation conditions. In spontaneous differentiation, both genes could disrupt differentiation. Conclusions: The 20q11.21 gain couples a persistent survival advantage with a disruption of neural and RPE lineage competence, redirecting cells toward alternative ectodermal and extraembryonic fates. These effects arise from the combined action of two dosage-sensitive genes BCL2L1 and ID1 within the amplicon, illustrating how regional gene dosage can reshape developmental signalling responses in hPSC.

10 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
YLYingnan Lei
Yingnan Lei
MDMai Chi Duong
Mai Chi Duong
NKNusa Krivec
Nusa Krivec
CJCharlotte Janssens
Charlotte Janssens
MRMarius Regin
Marius Regin
CSClaudia Spits
Claudia Spits
Chromosomal abnormalities acquired during cell culture can compromise the differentiation potential of human pluripotent stem cells (hPSCs). In this work, we identified a diminished differentiation capacity to retinal progenitor cells in human embryonic stem cells (hESCs) with loss of chromosome 18q. Time-course gene-expression analysis during spontaneous differentiation and single-cell RNA sequencing found that these variant cell lines poorly specified into anterior neuroectoderm, and, when progressing through differentiation, they yielded poorly pigmented cells, with proliferating and pluripotent cell populations. The variant cell lines showed dysregulation of TGFβ signaling during differentiation, and chemical modulation of the TGFβ pathways showed that the basis of the improper specification was due to imbalances in the anteroposterior neuroectodermal fate commitment.

30 September 2024 in Research Square
Verified
Preprint
Open access
PDF file
CSClaudia Spits
Claudia Spits
EDEdouard Couvreu de Deckersberg
Edouard Couvreu de Deckersberg
YLYingnan Lei
Yingnan Lei
NKNusa Krivec
Nusa Krivec
DDDiana Al Delbany
Diana Al Delbany
OTOlga Tsuiko
Olga Tsuiko
In this study, we show that undirected differentiation of human embryonic stem cells (hESC) to retinal pigment epithelium (RPE) acts as a selective barrier against aneuploid cells. Large-scale omics analysis reveals that 3–6% of cells of genetically normal hESC cultures are aneuploid, none of which progresses through RPE differentiation except for cells with a gain of 1q. We show that while all homogeneously aneuploid hESC lines carrying an array of different abnormalities have impaired RPE differentiation, co-culture with genetically normal cells specifically rescues the differentiation of cells with a gain of 1q. In turn, these aneuploid cells have an in vitro growth advantage, and progressively take over the differentiating culture. Time-course analysis shows that, only when co-cultured, cells with a gain of 1q follow the same differentiation path as genetically normal cells, which support the mutant cells by secreting extracellular matrix and ligands promoting differentiation.